And yet, it says 5 year survival “analysis”…
And multiple governmental agencies reviewed the data and chose not to fund it for most patients because the benefits were questionable for most patients. The UK only provides it to a narrow band if patients. Washington State went through a whole breakdown.
I’ve posted this stuff before. Plus you have statistical evidence problems that Flipper has gone through in relationship to overly
censoring and extrapolating the data.
Of course it is recommended, there has been so little progress that anything will get people’s attention. But it also only works on recurrent cancer tissue, and doesn’t have a clear explanation in terms of destroying tumor tissue.
So, whatever the case, there are many with incredible knowledge who have ongoing skepticism even as they will no doubt recommend the treatment because you always want to give hope.
Market Data 
Markets 
AI
